The New Zealand hepatitis B screening programme: Screening coverage and prevalence of chronic hepatitis B infection

New Zealand Medical Journal

Volumn 118, Issue 1211, 2005, Pages

  Robinson, Tom ^a   Bullen, Chris ^b   Humphries, Wendy ^c   Hornell, John ^c   Moyes, Chris ^c  

^a Diabetes Projects Trust   (New Zealand)

^b University of Auckland Clinical Trials Research Unit   (New Zealand)

^c Hepatitis Foundation   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASIAN; CHILD; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MAORI; MASS SCREENING; NEW ZEALAND; POPULATION RESEARCH; PREVALENCE; SCREENING TEST; SEX DIFFERENCE; ABORIGINE; BLOOD; ETHNOLOGY; IMMUNOLOGY; SEX RATIO;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; MALE; MASS SCREENING; NEW ZEALAND; OCEANIC ANCESTRY GROUP; PREVALENCE; SEX DISTRIBUTION;

EID: 21244491248     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Maddrey WC. Hepatitis B: an important public health issue. J Med Virol. 2000;61:362-6.
2. Milne A, Moyes CD. Hepatitis B carriage in children. N Z Med J.1983;96:238-41.
3. HermonYE, Mushahwar IK, Tobias MI. Hepatitis B infection in NZ children. N Z Med J.1984;97:887-9.
4. Miller JA, Hermon YE. Hepatitis B in pregnant women. N Z Med J.1984;97:461.
5. Milne A., Allwood GK, Moyes CD et al. Prevalence of hepatitis B infections in a multiracial New Zealand community. N Z Med J.1985;98:529-32.
6. Moyes CD, Milne A. Hepatitis B markers in 14-15 year olds in Bay of Plenty. N Z Med J.1986;99:662-4.
7. Tobias MI, Miller JA, Clements CJ, Patel AC. Hepatitis B in New Zealand children: the 1985 national immunisation survey. N Z Med J.1987;100:203-6.
8. Blakely T, Salmond C, Tobias M. Hepatitis B virus carrier prevalence in New Zealand: population estimates using the 1987 police and customs personnel survey. N Z Med J.1998;111:142-4.
9. Chapman BA, Burt MJ, Frampton CM, et al. The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community. N Z Med J.2000;113:394-6.
10. Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol. 2000;15 Suppl:E3-6.
11. Working Party on Hepatitis B. The feasibility of screening for and surveillance of hepatitis B in a single geographic area: report to the Director-General of Health. Wellington: Ministry of Health, 1996. Available online. URL: http://www.moh.govt.nz/moh.nsf/0/ e795f5b0cddb25274c256671000c194c?OpenDocument Accessed March 2005.
12. Ganem D, Prince AM. Hepatitis B Virus infection- natural history and clinical consequences. N Engl J Med. 2004;350:1118-29.
13. Paul C, Thomas M. Screening for hepatitis B carriers: a perspective from New Zealand. Aust N Z J Med.1997;27:698-705.
14. Blakely T, Bates M, Garrett N, Robson B. The incidence of hepatocellular carcinoma in New Zealand. N Z Med J. 1998;111:471-4.
15. Weir R, Brunton CR., Blakely TA. Chronic liver disease mortality attributable to hepatitis B and C in New Zealand. J Gastroenterol Hepatol. 2002;17:582-8.
16. Turner N, Baker M, Carr J, Mansoor O. Improving immunisation coverage: what needs to be done? N Z Pub Health Rep. 2000;7:11-14.
17. Blakely T, Thornley CN. Screening for hepatitis B carriers: evidence and policy development in New Zealand. N Z Med J.1999;112:431-3.
18. National Health Committee. Screening to improve health in New Zealand: criteria to assess screening programmes. Wellington: National Health Committee, 2003. Available online. URL: http://www.nhc.govt.nz/publications/ScreeningCriteria.pdf Accessed March 2005.
19. Greenland S. Basic methods for sensitivity analysis of biases. Int. J. Epidemiol.1996;25:1107-16.
20. Baker S. BreastScreen Aotearoa screening rates 2002. Wellington: National Screening Unit; 2003.
21. Medley GF, Lindop NA, Edmunds WJ, Nokes DJ. Hepatitis B virus endemicity: heterogeneity, catastrophic dynamics and control. Nat Med. 2001;7:619-24.
22. Hopkirk N, Moyes CD, Lucas CR. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand. N Z Med J. 2000;113:114-6.
23. Yuen MF, Lai CL. Treatment of chronic hepatitis B. Lancet Infect Dis. 2001;1:232-41.
24. Gow, P, Mutimer D. Treatment of chronic hepatitis. BMJ. 2001;323:1164-7.
25. Wun YT, Dickinson JA. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B. Cochrane Database Syst Rev. 2003;(2):CD002799.
26. Lok AS, McMahon B. Chronic hepatitis B: Update of recommendations. Hepatology.2004;39:857-61.
27. Edmunds WJ, Medley GF, Nokes DJ. The transmission dynamics and control of hepatitis B virus in The Gambia. Stat Med.1996;15:2215-23.